Zahna Bigham1, Yvonne Robles2, Karen M Freund1,3, Julie R Palmer2, Kimberly A Bertrand4. 1. Tufts University School of Medicine and Graduate School of Biomedical Sciences, Boston, MA, USA. 2. Slone Epidemiology Center at Boston University, 72 East Concord Street, L-7, Boston, MA, USA. 3. Department of Medicine, Tufts Medical Center, Boston, MA, USA. 4. Slone Epidemiology Center at Boston University, 72 East Concord Street, L-7, Boston, MA, USA. kab15@bu.edu.
Abstract
PURPOSE: Compared to white women, Black women have increased risk of developing hypertensive diseases of pregnancy (HDOP) and have a higher incidence of aggressive breast cancer subtypes. Few studies of HDOP and breast cancer risk have included large numbers of Black women. This study examined the relation of HDOP to incidence of breast cancer overall and by estrogen receptor (ER) status in Black women. METHODS: We followed 42,982 parous women in the Black Women's Health Study, a nationwide prospective study of Black women. Multivariable Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) to assess associations of self-reported HDOP, including preeclampsia and gestational hypertension, with breast cancer incidence overall and by ER subtype, adjusted for age and established breast cancer risk factors. RESULTS: Over 20 years of follow-up, we identified 2376 incident breast cancer cases. History of HDOP (11.7%) was not associated with breast cancer risk overall (HR 0.98; 95% CI 0.87, 1.11). HRs for invasive ER+ and ER- breast cancer were 1.11 (95% CI 0.93, 1.34) and 0.81 (95% CI 0.61, 1.07), respectively. CONCLUSIONS: HDOP was not associated with risk of overall breast cancer in Black women. A suggestive inverse association with ER- breast cancer may reflect an anti-tumorigenic hormone profile in HDOP, but those results require confirmation in other studies.
PURPOSE: Compared to white women, Black women have increased risk of developing hypertensive diseases of pregnancy (HDOP) and have a higher incidence of aggressive breast cancer subtypes. Few studies of HDOP and breast cancer risk have included large numbers of Black women. This study examined the relation of HDOP to incidence of breast cancer overall and by estrogen receptor (ER) status in Black women. METHODS: We followed 42,982 parous women in the Black Women's Health Study, a nationwide prospective study of Black women. Multivariable Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) to assess associations of self-reported HDOP, including preeclampsia and gestational hypertension, with breast cancer incidence overall and by ER subtype, adjusted for age and established breast cancer risk factors. RESULTS: Over 20 years of follow-up, we identified 2376 incident breast cancer cases. History of HDOP (11.7%) was not associated with breast cancer risk overall (HR 0.98; 95% CI 0.87, 1.11). HRs for invasive ER+ and ER- breast cancer were 1.11 (95% CI 0.93, 1.34) and 0.81 (95% CI 0.61, 1.07), respectively. CONCLUSIONS: HDOP was not associated with risk of overall breast cancer in Black women. A suggestive inverse association with ER- breast cancer may reflect an anti-tumorigenic hormone profile in HDOP, but those results require confirmation in other studies.
Authors: Mary Beth Terry; Mary Perrin; Carolyn M Salafia; Fang Fang Zhang; Alfred I Neugut; Susan L Teitelbaum; Julie Britton; Marilie D Gammon Journal: Am J Epidemiol Date: 2007-02-06 Impact factor: 4.897
Authors: Anna Hübinette; Paul Lichtenstein; Kerstin Brismar; Lars Vatten; Geir Jacobsen; Anders Ekbom; Sven Cnattingius Journal: Acta Obstet Gynecol Scand Date: 2003-11 Impact factor: 3.636
Authors: Courtenay L Diehl; Brian C Brost; Marie C Hogan; Ahmad A Elesber; Keneth P Offord; Stephen T Turner; Vesna D Garovic Journal: Am J Obstet Gynecol Date: 2008-02-01 Impact factor: 8.661